Drug-induced hepatotoxicity

New England Journal of Medicine

Volumn 333, Issue 17, 1995, Pages 1118-1127

  Lee, William M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; CARBAMAZEPINE; CEFALEXIN; DIAZEPAM; DILTIAZEM; ESTRIOL; HALOTHANE; HYDRALAZINE; ISONIAZID; METHOTREXATE; METHYLDOPA; METOLAZONE; MEVINOLIN; NITROFURANTOIN; OXYPHENBUTAZONE; PARACETAMOL; PENICILLIN G; PHENYTOIN; PROCAINAMIDE; PROCARBAZINE; QUINIDINE; SULFONAMIDE; SULFONYLUREA DERIVATIVE; TERBUTALINE; TICLOPIDINE; TRAZODONE; TRICHLORMETHIAZIDE; UNINDEXED DRUG;

CHOLESTASIS; CHRONIC HEPATITIS; DRUG ABUSE; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; FATTY LIVER; HUMAN; LIVER CIRRHOSIS; LIVER GRANULOMA; LIVER TOXICITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

BIOTRANSFORMATION; DRUG INTERACTIONS; HUMAN; LIVER; LIVER DISEASES; PHARMACEUTICAL PREPARATIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0028817867     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199510263331706     Document Type: Review

References (101)

1. Zimmerman HJ, Maddrey WC. Toxic and drug-induced hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver. Philadelphia: J.B. Lippincott, 1993.
2. Kaplowitz N. Drug metabolism and hepatotoxicity. In: Kaplowitz N, ed. Liver and biliary diseases. Baltimore: Williams and Wilkins, 1991.
3. Farrell GC. Drug-induced liver disease. Edinburgh, Scotland: Churchill Livingstone, 1994.
4. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187: 211-217
5. Baerg RD, Kimberg DV Centrilobular hepatic necrosis and acute renal failure in “solvent sniffers.“ Ann Intern Med 1970; 73: 713-720
6. Klein AS, Hart J, Brems JJ, Goldstein L, Lewin K, Busuttil RW Amanita poisoning: treatment and the role of liver transplantation. Am J Med 1989; 86: 187-193
7. Gonzalez FJ Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 1992; 13: 346-352
8. Watkins PB Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992; 21: 511-526
9. Murray M P450 enzymes: inhibition mechanisms, genetic regulation and effects of liver disease. Clin Pharmacokinet 1992; 23: 132-146
10. Guengerich FP Human cytochrome P-450 enzymes. Life Sci 1992; 50: 1471-1478
11. Takahashi T, Lasker JM, Rosman AS, Lieber CS Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993; 17: 236-245
12. French SW, Wong K, Jui L, Albano E, Hagbjork AL, Ingelman-Sundberg M Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology and pathogenesis. Exp Mol Pathol 1993; 58: 61-75
13. Roe AL, Snawder JE, Benson RW, Roberts DW, Casciano DA HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun 1993; 190: 15-19
14. Prescott LF, Illingworth RN, Critchley JAH, Stewart MJ, Adam RD, Proudfoot AT Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2: 1097-1100
15. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the National Multicenter Study (1976 to 1985). N Engl J Med 1988; 319: 1557-1562
16. Wolff T, Strecker M Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes. Exp Toxicol Pathol 1992; 44: 263-271
17. Bonkovsky HL, Kane RE, Jones DP, Galinsky RE, Banner B Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology 1994; 19: 1141-1148
18. Beaune PH, Bourdi M Autoantibodies against cytochromes P-450 in drug-induced autoimmune hepatitis. Ann N Y Acad Sci 1993; 685: 641-645
19. Hunt CM, Westerkam WR, Stave GM, Wilson JA Hepatic cytochrome P-4503A (CYP3A) activity in the elderly. Mech Ageing Dev 1992; 64: 189-199
20. Hunt CM, Westerkam WR, Stave GM Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992; 44: 275-283
21. Yoo JS, Smith TJ, Ning SM, Lee MJ, Thomas PE, Yang CS Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid. Biochem Pharmacol 1992; 43: 2535-2542
22. Barnett CR, Abbott RA, Bailey CJ, Flatt PR, Ioannides C Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochem Pharmacol 1992; 43: 1868-1871
23. Ikemoto S, Imaoka S, Hayahara N, Maekawa M, Funae Y Expression of hepatic microsomal cytochrome P450s as altered by uremia. Biochem Pharmacol 1992; 43: 2407-2412
24. Kurokohchi K, Yoneyama H, Matsuo Y, Nishioka M, Ichikawa Y Effects of interleukin 1 alpha on the activities and gene expressions of the cytochrome P450IID subfamily. Biochem Pharmacol 1992; 44: 1669-1674
25. Wrighton SA, Stevens JC The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992; 22: 1-21
26. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986; 104: 399-404
27. Whitcomb DC, Block GD Association of acetaminophen hepatotoxicity with fasting and alcohol use. JAMA 1994; 272: 1845-1850
28. Brotodihardjo AE, Batey RG, Farrell GC, Byth K Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med J Aust 1992; 157: 382-385
29. Lee WM Acute liver failure. N Engl J Med 1993; 329: 1862-1872
30. Smilkstein MJ, Douglas DR, Daya MR, Acetaminophen poisoning and liver function. N Engl J Med 1994; 331: 1310-1312
31. Garibaldi RA, Drusin RE, Ferebee SH, Gregg MB Isoniazid-associated hepatitis: report of an outbreak. Am Rev Respir Dis 1972; 106: 357-365
32. Mitchell I, Wendon J, Fitt S, Williams R Anti-tuberculous therapy and acute liver failure. Lancet 1995; 345: 555-556
33. Ramakrishna B, Viswanath N Diclofenac-induced hepatitis: case report and literature review. Liver 1994; 14: 83-84
34. Lindenbaum J, Leifer E Hepatic necrosis associated with halothane anesthesia. N Engl J Med 1963; 268: 525-530
35. Gut J, Christen U, Huwyler J Mechanisms of halothane toxicity: novel insights. Pharmacol Ther 1993; 58: 133-155
36. Scheider DM, Klygis LM, Tsang TK, Caughron MC Hepatic dysfunction after repeated isoflurane administration. J Clin Gastroenterol 1993; 17: 168-170
37. Kleckner HB, Yakulis V, Heller P Severe hypersensitivity to diphenylhydantoin with circulating antibodies to the drug. Ann Intern Med 1975; 83: 522-523
38. Pohl LR Drug-induced allergic hepatitis. Semin Liver Dis 1990; 10: 305-315
39. Mazuryk H, Kastenberg D, Rubin R, Munoz SJ Cholestatic hepatitis associated with the use of nafcillin. Am J Gastroenterol 1993; 88: 1960-1962
40. Reynolds TB, Peters RL, Yamada S Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 1971; 285: 813-820
41. Lee WM, Denton WT Chronic hepatitis and indolent cirrhosis due to methyldopa: the bottom of the iceberg? J S C Med Assoc 1989; 85: 75-79
42. Barker JD Jr, de Carle DJ, Anuras S Chronic excessive acetaminophen use and liver damage. Ann Intern Med 1977; 87: 299-301
43. Reinhart HH, Reinhart E, Korlipara P, Peleman R Combined nitrofurantoin toxicity to liver and lung. Gastroenterology 1992; 102: 1396-1399
44. Rigas B, Rosenfeld LE, Barwick KW, Amiodarone hepatotoxicity: a clinicopathologic study of five patients. Ann Intern Med 1986; 104: 348-351
45. Gehenot M, Horsmans Y, Rahier J, Geubel AP Subfulminant hepatitis requiring liver transplantation after benzarone administration. J Hepatol 1994; 20: 842-842
46. Morelli S, Guido V, De Marzio P, Aguglia F, Balsano F Early hepatitis during intravenous amiodarone administration. Cardiology 1991; 78: 291-294
47. Lewis JH, Ranard RC, Caruso A, Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989; 9: 679-685
48. Gradon JD, Chapnick EK, Sepkowitz DV Zidovudine-induced hepatitis. J Intern Med 1992; 231: 317-318
49. Freiman JP, Helfert KE, Hamrell MR, Stein DS Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7: 379-385
50. Chattha G, Arieff AI, Cummings C, Tierney LM Jr Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118: 37-39
51. Lai KK, Gang DL, Zawacki JK, Cooley TP Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI). Ann Intern Med 1991; 115: 283-284
52. Touchette N HBV-drug deaths prompt restudy of similar antivirals. J NIH Res 1993; 5: 33-35
53. Macilwain C NIH, FDA seek lessons from hepatitis B drug trial deaths. Nature 1993; 364: 275-275
54. McKenzie R, Fried MW, Sallie R, Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995; 333: 1099-1105
55. Newman M, Auerbach R, Feiner H, The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment: improvement in liver abnormalities after cessation of treatment. Arch Dermatol 1989; 125: 1218-1224
56. O'Connor GT, Olmstead EM, Zug K, Detection of hepatoxicity associated with methotrexate therapy for psoriasis. Arch Dermatol 1989; 125: 1209-1217
57. Geubel AP, De Galocsy C, Alves N, Rahier J, Dive C Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 1991; 100: 1701-1709
58. McDonald GB, Hinds MS, Fisher LD, Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267
59. Silva MO, Roth D, Reddy KR, Fernandez JA, Albores-Saavedra J, Schiff ER Hepatic dysfunction accompanying acute cocaine intoxication. J Hepatol 1991; 12: 312-315
60. Boyer CS, Peterson DR Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res 1990; 14: 28-31
61. Van Thiel DH, Perper JA Hepatotoxicity associated with cocaine abuse. Recent Dev Alcohol 1992; 10: 335-341
62. Dalton TA, Berry RS Hepatotoxicity associated with sustained-release niacin. Am J Med 1992; 93: 102-104
63. Henry JA, Jeffreys KJ, Dawling S Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy“). Lancet 1992; 340: 384-387
64. Fallon MB, Boyer JL Hepatic toxicity of vitamin A and synthetic retinoids. J Gastroenterol Hepatol 1990; 5: 334-342
65. Larrey D, Vial T, Pauwels A, Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117: 129-132
66. Loeper J, Descatoire V, Letteron P, Hepatotoxicity of germander in mice. Gastroenterology 1994; 106: 464-472
67. Katz M, Saibil F Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990; 12: 203-206
68. Chaparral-induced toxic hepatitis -- California and Texas, 1992 MMWR Morb Mortal Wkly Rep 1992; 41: 812-814
69. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC Hepatotoxicity of herbal remedies. BMJ 1989; 299: 1156-1157
70. Woolf GM, Petrovic LM, Rojter SE, Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994; 121: 729-735
71. Alberti-Flor JJ, Hernandez ME, Ferrer JP, Howell S, Jeffers L Fulminant liver failure and pancreatitis associated with the use of sulfamethoxazole-trimethoprim. Am J Gastroenterol 1989; 84: 1577-1579
72. Larrey D, Vial T, Micaleff A, Hepatitis associated with amoxycillin-clavulanic acid combination: report of 15 cases. Gut 1992; 33: 368-371
73. Hebbard GC, Smith KG, Gibson PR, Bhathal PS Augmentin-induced jaundice with a fatal outcome. Med J Aust 1992; 156: 285-286
74. Westphal JF, Vetter D, Brogard JM Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994; 33: 387-401
75. Chiu J, Nussbaum J, Bozzette S, Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med 1990; 113: 358-361
76. Medina I, Mills J, Leoung G, Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 1990; 323: 776-782
77. Saliba B, Herbert PN Oxacillin hepatotoxicity in HIV-infected patients. Ann Intern Med 1994; 120: 1048-1048
78. Schiff ER, Maddrey WC Can we prevent nonsteroidal anti-inflammatory drug-induced hepatic failure? Gastrointest Dis Today 1994; 3: 7-13
79. Carson JL, Strom BL, Duff A, Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 1993; 119: 576-583
80. O'Grady JG, Alexander GJM, Hayllar KM, Williams R Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445
81. Zimmerman HJ, Lewis JH, Ishak KG, Maddrey WC Ticrynafen-associated hepatic injury: analysis of 340 cases. Hepatology 1984; 4: 315-323
82. Powers BJ, Cattau EL Jr, Zimmerman HJ Chlorzoxazone hepatotoxic reactions: an analysis of 21 identified or presumed cases. Arch Intern Med 1986; 146: 1183-1186
83. Kellner M, Wiedemann K, Krieg JC, Berg PA Toxic hepatitis by clozapine treatment. Am J Psychiatry 1993; 150: 985-986
84. Purcell P, Henry D, Melville G Diclofenac hepatitis. Gut 1991; 32: 1381-1385
85. Keegan AD Doxepin-induced recurrent acute hepatitis. Aust N Z J Med 1993; 23: 523-523
86. Tran A, Housset C, Boboc B, Tourani JM, Carnot F, Berthelot P Etoposide (VP 16-213) induced hepatitis: report of three cases following standard-dose treatments. J Hepatol 1991; 12: 36-39
87. Kano Y, Fukuda M, Shiohara T, Nagashima M Cholestatic hepatitis occurring shortly after etretinate therapy. J Am Acad Dermatol 1994; 31: 133-134
88. Davies MH, Harrison RF, Elias E, Hubscher SG Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis. J Hepatol 1994; 20: 112-116
89. Wysowski DK, Freiman JP, Tourtelot JB, Horton ML III Fatal and nonfatal hepatotoxicity associated with flutamide. Ann Intern Med 1993; 118: 860-864
90. Meadow P, Tullio CJ Glyburide-induced hepatitis. Clin Pharm 1989; 8: 470-470
91. Knight TE, Shikuma CY, Knight J Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol 1991; 25: 398-400
92. Michelson EJ Labetalol hepatotoxicity. Ann Intern Med 1991; 114: 341-341
93. Larrey D, Babany G, Bernuau J, Fulminant hepatitis after lisinopril administration. Gastroenterology 1990; 99: 1832-1833
94. Raveh D, Arnon R, Israeli A, Eisenberg S Lovastatin-induced hepatitis. Isr J Med Sci 1992; 28: 101-102
95. Lopez-Navidad A, Domingo P, Cadafalch J, Farrerons J Norfloxacin-induced hepatotoxicity. J Hepatol 1990; 11: 277-278
96. Blum A Ofloxacin-induced acute severe hepatitis. South Med J 1991; 84: 1158-1158
97. Picon M, Causse X, Gelas P, Retornaz G, Trepo C, Bouletreau P Hépatite aiguë sévère àla pentamidine au cours du traitement d'une pneumocystose liée au SIDA. Gastroenterol Clin Biol 1991; 15: 463-464
98. Planas R, De Leon R, Quer JC, Barranco C, Bruguera M, Gassull MA Fatal submassive necrosis of the liver associated with piroxicam. Am J Gastroenterol 1990; 85: 468-470
99. Quinn PG, Sherman BS, Tavill AS, Gibas AL Terbutaline hepatitis in pregnancy: report of two cases and literature review. Am J Gastroenterol 1994; 89: 781-784
100. Grimm IS, Litynski JJ Severe cholestasis associated with ticlopidine. Am J Gastroenterol 1994; 89: 279-280
101. Hull M, Jones R, Bendall M Fatal hepatic necrosis associated with trazodone and neuroleptic drugs. BMJ 1994; 309: 378-378